Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

e-ESO Podcasts - Podcast autorstwa ESO - European School of Oncology

Kategorie:

Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil

Visit the podcast's native language site